@article{20a0380a3f6d4fec85d43d9ca35b45a3,
title = "A Phase 2 Randomized, Double-Blind, Placebo–Controlled Study of the Safety and Efficacy of Talactoferrin in Patients with Severe Sepsis",
keywords = "Lactoferrin, Septic shock, Severe sepsis, Talactoferrin alfa",
author = "\{TLF LF-0801 Investigator Group\} and Kalpalatha Guntupalli and Nathan Dean and Morris, \{Peter E.\} and Venkata Bandi and Benjamin Margolis and Rivers, \{Emanuel P.\} and Mitchell Levy and Lodato, \{Robert F.\} and Ismail, \{Preeti M.\} and Amber Reese and Schaumberg, \{John P.\} and Rajesh Malik and Dellinger, \{R. Phillip\} and Alejandro Arroliga and Balk, \{Robert A.\} and Cannon, \{Chad M.\} and Nathan Dean and Dellinger, \{R. Phillip\} and Paula Dennen and Juan Figueroa and Eugene Fletcher and Guntupalli, \{Kalpalatha K.\} and Huang, \{David T.\} and Mitchell Levy and Takkin Lo and Imrana Malik and Benjamin Margolis and George Matuschak and Laura Moore and Moran, \{Gregory J.\} and Eugene Moretti and Peter Morris and Edward Panacek and Emanual Rivers and Greg Schmidt and Seneff, \{Michael G.\} and Jay Steingrub and Robert Taylor",
year = "2013",
month = mar,
doi = "10.1097/CCM.0b013e3182741551",
language = "American English",
volume = "41",
pages = "706--716",
journal = "Critical Care Medicine",
issn = "0090-3493",
number = "3",
}